Westmount Partners’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,000
| Closed | -$106K | – | 250 |
|
|
2024
Q4 | $106K | Hold |
11,000
| – | – | 0.03% | 214 |
|
|
2024
Q3 | $31.5K | Hold |
11,000
| – | – | 0.01% | 224 |
|
|
2024
Q2 | $33.1K | Hold |
11,000
| – | – | 0.01% | 214 |
|
|
2024
Q1 | $35.1K | Hold |
11,000
| – | – | 0.01% | 208 |
|
|
2023
Q4 | $37K | Hold |
11,000
| – | – | 0.02% | 197 |
|
|
2023
Q3 | $26.2K | Hold |
11,000
| – | – | 0.01% | 190 |
|
|
2023
Q2 | $19.4K | Hold |
11,000
| – | – | 0.01% | 184 |
|
|
2023
Q1 | $33.9K | Hold |
11,000
| – | – | 0.02% | 179 |
|
|
2022
Q4 | $58.3K | Buy |
+11,000
| New | +$58.3K | 0.03% | 167 |
|